@article {331, title = {Education and Training Research Policy in Pharmacy Practice}, journal = {International Journal of Pharmacology and Clinical Sciences}, volume = {11}, year = {2022}, month = {June 2022}, pages = {48-55}, type = {Review Article}, chapter = {48}, abstract = {

Objectives: This study explores the Research policy of Research Education and Training in pharmacy practice as a new initiative in Saudi Arabia. Methods: The current topic is a narrative review of education and training procedures in pharmacy research. Litterateur was searched in various databases. That includes PubMed, Medline, Google Scholar, and academic Microsoft. The period covered for the search is from the 1960s to October 2021. The terms used are in the English language and encompass narrative reviews, systemic reviews, meta-analyses, and guidelines. The search keyword includes all hospital and community pharmacy-related services. Moreover, there are national and international guidelines for conducting general research in research in pharmacy practice. The committee of pharmacy research was formed and comprised numerous expert members, including clinical pharmacists, drug information pharmacists, and clinical research specialists. A member drafted the policy{\textquoteright}s guidelines, which were then reviewed and corrected by another member. The research specialist made the third revision. The topic emphasizes the Pharmacy Research policy of Research Education and Training. Results: Pharmacy Research{\textquoteright}s policy on Research Education and Training covered various topics, including the program objectives, admission requirements, teaching, educational methodology, and steps in pharmacy practice involving research, education, and training. Five models were used in research education and training. For instance, skills in searching for and reviewing the literature, research design and methodology, survey design, biostatistics, and research proposal writing. In addition, each model included a description of the module and Learning Objectives, Module Outlines, and Competency Items. Conclusion: The pharmacy research policy is a new initiative and a component of the pharmacy strategic plan. The Research Education and Training pharmacy policy aims to enhance pharmacists{\textquoteright} research abilities and encourage pharmacists to conduct various types of research in multiple settings within the public and healthcare sectors. Therefore, the Research Education and Training policy are critical for the pharmacy career in Saudi Arabia.

}, keywords = {Education, Pharmacy, Policy, Research, Saudi Arabia, Training}, doi = {10.5530/ijpcs.2022.11.10}, author = {Yousef Ahmed Alomi and Amal Hassan Al-Najjar and Maha Hussein Almadany and Abeer Hussin Almasoudi} } @article {330, title = {Research Policy: Narrative Review in Pharmacy Practice}, journal = {International Journal of Pharmacology and Clinical Sciences}, volume = {11}, year = {2022}, month = {June 2022}, pages = {41-47}, type = {Review Article}, chapter = {41}, abstract = {

Objectives: This study illustrates the Research policy of narrative review design in pharmacy practice as a new initiative in Saudi Arabia. Methods: This article is a narrative review of pharmacy research. Litterateur researched specific research policies and procedures in pharmacy practice using a variety of databases, including PubMed, Medline, and Google Scholar. The period covered for the search is from the 1960s to October 2021. The terms used are English and encompass systemic reviews, meta-analyses, narrative reviews, and guidelines. The search term includes all hospital and community pharmacy-related services. Besides, there are national and international guidelines for conducting general research in hospital and pharmacy practice. The committee of narrative review pharmacy research committee was formed. It consisted of numerous expert members, including clinical pharmacists, drug information pharmacists, and clinical research specialists. A member drafted the policy{\textquoteright}s guidelines, which were then reviewed and corrected by another member. The research specialist made the third revision. The topic emphasizes the Pharmacy Research policy of the narrative review model. Results: Pharmacy Research{\textquoteright}s policy on the narrative review model in pharmaceutical care services covered various topics, including the advantages and disadvantages of narrative review, the steps involved in conducting a drug review model, the steps involved in conducting disease drug therapy, and the steps involved in operating a new project in pharmacy practice. Conclusion: The narrative review policy for pharmacy research is a new initiative within pharmacy research. The narrative review pharmacy policy facilitates communication between healthcare professionals regarding recent drug reviews and disease-specific drug therapy. Besides, the pharmacy is embarking on a new endeavor with a healthcare organization. Therefore, all narrative review models in pharmacy research policy are highly recommended for the careers of Saudi Arabian pharmaceutical professionals.

}, keywords = {Disease drug therapy, Drug review, Narrative review, New project, Pharmacy, Policy, Research, Saudi Arabia}, doi = {10.5530/ijpcs.2022.11.9}, author = {Yousef Ahmed Alomi and Amal Hassan Al-Najjar and Maha Hussein Almadany and Abeer Hussin Almasoudi} } @article {329, title = {Research Policy of Case Report and Case Series Design}, journal = {International Journal of Pharmacology and Clinical Sciences}, volume = {11}, year = {2022}, month = {June 2022}, pages = {36-40}, type = {Review Article}, chapter = {36}, abstract = {

Objectives: This study aims to declare the Research policy of case reports and case series design in pharmacy practice as a new initiative in Saudi Arabia. Methods: This article is a narrative review of pharmacy research. Litterateur looked up specific research policies and procedures in pharmacy practice in databases such as PubMed, Medline, and Google Scholar. The time frame for the search was from the 1960s to October 2021. The terms used are in the English language and encompasses narrative reviews, systemic reviews, meta-analyses, and guidelines. The search term includes all hospital and community pharmacy-related services. Besides, there are national and international guidelines for conducting general research in hospital practice was revised. The pharmacy research committee was formed and consisted of expert members, including clinical pharmacists, pharmacists who specialise in drug information, and clinical research specialists. A member drafted the policy{\textquoteright}s guidelines, which were then reviewed and corrected by another member. The research specialist made the third revision. The topic emphasizes the Pharmacy Research policy of case reports and case series design. Results: The Pharmacy Research policy regarding the design of case reports and case series in pharmaceutical care services included several items. This included the advantages and disadvantages of case reports and case series, the steps involved in conducting case report research, and the steps involved in implementing the case series model in pharmacy practice. Conclusion: The case report and case series policy in pharmacy is a new initiative that is part of the pharmacy research services and the pharmacy strategic plan. The case report and case series pharmacy policies help a healthcare organisation address its unique drug related issues. Additionally, the efficacy of the particular drug in treating the particular disease condition. Therefore, in Saudi Arabia, the case report and case series in pharmacy research policy are highly recommended.

}, keywords = {Case report, Case series, Pharmacy, Policy, Research, Saudi Arabia}, doi = {10.5530/ijpcs.2022.11.8}, author = {Yousef Ahmed Alomi and Amal Hassan Al-Najjar and Esraa S. Altawil and Maha Hussein Almadany and Ghudair Tashan Alanazi and Abeer Hussin Almasoudi} } @article {323, title = {Research Policy of the Institutional Review Board in Pharmacy Practice}, journal = {International Journal of Pharmacology and Clinical Sciences}, volume = {11}, year = {2022}, month = {April 2022}, pages = {15-19}, type = {Review Article}, chapter = {15}, abstract = {

Objectives: This study aims to declare the Research policy of the Institutional Review Board at pharmaceutical care services as a new initiative in Saudi Arabia. Methods: This article is a narrative review of pharmacy research. Litterateur researched specific research policies and procedures in pharmacy practice using a variety of databases, including PubMed, Medline, and Google Scholar. The period covered for the search is from the 1960s to October 2021. The terms used are in the English language and encompasses narrative reviews, systemic reviews, meta-analyses, and guidelines. The search term includes all hospital and community pharmacy-related services. Besides, there are national and international guidelines for conducting general research in hospital practice. The pharmacy research committee was formed and comprised numerous expert members, including clinical pharmacists, pharmacists specializing in drug information, and clinical research specialists. A member drafted the policy{\textquoteright}s guidelines, which were then reviewed and corrected by another member. The research specialist made the third revision. The subject emphasizes the research policy of the Institutional Review Board in pharmacy practice. Results: The Institutional Review Board{\textquoteright}s definition and functions were examined. The policies and procedures have been established. In pharmacy research, there were three distinct categories of actions. That includes Exempted Research, in which no risks to patients are involved. For example, a review of a new program or service, a cost analysis, therapeutic guidelines, review articles, a systematic review, a meta-analysis, or a cross-sectional study. Expedited Research posed little risk to patients. The Complete revision Research has a high risk of adverse effects on patients, such as clinical trials. Conclusion: The Institutional Review Board for research policies in pharmaceutical care services is a new initiative within pharmacy departments{\textquoteright} research and development efforts. The Institutional Review Board for research policies in pharmaceutical care services may enhance pharmacy research and the benefits of investments in pharmacy practice within a healthcare organization. Besides, prevent any adverse events associated with the investigational drug and improve patient clinical outcomes.

}, keywords = {Institutional Review Board, Pharmacy, Policy, Practice, Research, Saudi Arabia.}, doi = {10.5530/ijpcs.2022.11.4}, author = {Yousef Ahmed Alomi and Amal Hassan Al-Najjar and Hamidah Qasim Ali Abushomi and Maha Hussein Almadany and Abeer Hussin Almasoudi} } @article {321, title = {Research Policy of the Investigational Drugs in the Clinical Trial}, journal = {International Journal of Pharmacology and Clinical Sciences}, volume = {11}, year = {2022}, month = {April 2022}, pages = {03-08}, type = {Review Article}, chapter = {03}, abstract = {

Objectives: This study aims to explore the research policy of investigational drugs in the clinical trial as a new initiative in Saudi Arabia. Methods: This article is a narrative review of pharmacy research. Litterateur researched specific research policies and procedures in pharmacy practice using a variety of databases, including PubMed, Medline, and Google Scholar. The period covered for the search is from the 1960s to October 2021. The terms used are in the English language and encompasses narrative reviews, systemic reviews, meta-analyses, and guidelines. The search term encompasses all hospital and community pharmacy-related services. Besides, there are national and international guidelines for conducting general research in hospital practice. The pharmacy research committee was formed and comprised numerous expert members, including clinical pharmacists, pharmacists specializing in drug information, and clinical research specialists. A member drafted the policy{\textquoteright}s guidelines, which were then reviewed and corrected by another member. The research specialist made the third revision. The subject emphasizes the research policy for investigational drugs in the clinical trial. Results: A general policy was established for investigational drugs in clinical trials, which included defining clinical trials and addressing related issues. Clinical trial approval policy, the role of the Institutional Review Board, the clinical responsibilities of the research team, and patient informed consent. Apart from that, clinical trials require patient records and auditing. Conclusion: The research policy for investigational drugs in a clinical trial is a novel initiative within pharmaceutical care research and development. The research policy for investigational drug in clinical trials protects patient rights and safety. Additionally, encourage pharmacy services to implement and conduct clinical trials in pharmacy practice at healthcare institutions of Saudi Arabia.

}, keywords = {Clinical trial, Drug, Investigational, Policy, Research, Saudi Arabia}, doi = {10.5530/ijpcs.2022.11.2}, author = {Yousef Ahmed Alomi and Amal Hassan Al-Najjar and Hamidah Qasim Ali Abushomi and Maha HusseinAlmadany and Abeer Hussin Almasoudi} } @article {324, title = {Research Policy of the Research Data Management in Pharmacy Practice}, journal = {International Journal of Pharmacology and Clinical Sciences}, volume = {11}, year = {2022}, month = {April 2022}, pages = {20-24}, type = {Review Article}, chapter = {20}, abstract = {

Objectives: This study aims to declare the research policy of Data management in pharmaceutical care services as a new initiative in Saudi Arabia. Methods: This article is a narrative review of pharmacy research. Litterateur researched specific research policies and procedures in pharmacy practice using a variety of databases, including PubMed, Medline, and Google Scholar. The period covered for the search is from the 1960s to October 2021. The terms used are in the English language and encompasses narrative reviews, systemic reviews, meta-analyses, and guidelines. The search term includes all hospital and community pharmacy-related services. Besides, there are national and international guidelines for conducting general research in hospital practice. The pharmacy research committee was formed and comprised numerous expert members, including clinical pharmacists, pharmacists specializing in drug information, and clinical research specialists. A member drafted the policy{\textquoteright}s guidelines, which were then reviewed and corrected by another member. The research specialist made the third revision. The subject emphasizes the Research policy of Data management in pharmaceutical care services. Results: The data management policy for research at pharmaceutical care services was established. That includes the design of the data collection, the data resources, and the data collector. Additionally, the data preparation for analysis, the data{\textquoteright}s reliability and validity, and storage data. Conclusion: The Data management policy for research in pharmacy practice is a new initiative as part of pharmacy departments{\textquoteright} research and development efforts. Data management in pharmacy care services may increase the documentation of pharmacist research and activities. The basic foundation of pharmacy analytics is the new vision of pharmacy career professionals.

}, keywords = {Data management, Pharmaceutical Care, Policy, Research, Saudi Arabia, Services}, doi = {10.5530/ijpcs.2022.11.5}, author = {Yousef Ahmed Alomi and Amal Hassan Al-Najjar and Hamidah Qasim Ali Abushomi and Maha Hussein Almadany and Abeer Hussin Almasoudi} } @article {325, title = {Research Policy on Case-control and Cohort Study Design in Pharmaceutical Care}, journal = {International Journal of Pharmacology and Clinical Sciences}, volume = {11}, year = {2022}, month = {April 2022}, pages = {25-30}, type = {Review Article}, chapter = {25}, abstract = {

Objectives: This study explores the Research Policy of Case-Control and Cohort Study Design in Pharmacy Practice as a new initiative in Saudi Arabia. Methods: This article is a narrative review of pharmacy research. Litterateur researched specific research policies and procedures in pharmacy practice using a variety of databases, including PubMed, Medline, and Google Scholar. The period covered for the search is from the 1960s to October 2021. The terms used are in the English language and encompasses narrative reviews, systemic reviews, meta-analyses, and guidelines. The search term includes all hospital and community pharmacy-related services. Besides, there are national and international guidelines for conducting general research in hospital practice. The pharmacy research committee was formed and comprised numerous expert members, including clinical pharmacists, pharmacists specializing in drug information, and clinical research specialists. A member drafted the policy{\textquoteright}s guidelines, which were then reviewed and corrected by another member. The research specialist made the third revision. The subject emphasizes the Pharmacy Research Policy for the Case-Control and Cohort Study Model. Results: The Pharmacy Research policy for the Case-Control and Cohort Study Design in pharmaceutical care services consisted of several components, including the advantages and disadvantages of Case-Control and Cohort Study Design and the steps involved in conducting Case-Control research, and the steps involved in conducting Cohort Study research in pharmacy practice. Conclusion: The pharmacy research policy for the Case-Control and Cohort Study Design is a new initiative as part of the pharmaceutical care services. The pharmacy policy on Case-Control and Cohort Studies aims to improve pharmacists{\textquoteright} research abilities in healthcare institutions. Additionally, the new tools for documenting and validating adverse drug reactions. Therefore, the Case-Control and Cohort Study research policies in pharmacy are recommended for implementation in Saudi Arabia.

}, keywords = {Case-Control, Cohort Study, Pharmacy, Policy, Research, Saudi Arabia}, doi = {10.5530/ijpcs.2022.11.6}, author = {Yousef Ahmed Alomi and Amal Hassan Al-Najjar and Maha Hussein Almadany and Fakhar Al-Ayoubi and Ghudair Tashan Alanazi and Abeer Hussin Almasoudi} } @article {327, title = {Research Policy on Cross-Sectional Studies in Pharmacy Practice}, journal = {International Journal of Pharmacology and Clinical Sciences}, volume = {11}, year = {2022}, month = {June 2022}, pages = {31-35}, type = {Review Article}, chapter = {31}, abstract = {

Objectives: This study illustrates the Research policy of Cross-Sectional Studies in Pharmaceutical Care Services as a new initiative in Saudi Arabia. Methods: This article is a narrative review of pharmacy research. Litterateur researched specific research policies and procedures in pharmacy practice using a variety of databases, including PubMed, Medline, and Google Scholar. The period covered for the search is from the 1960s to October 2021. The terms used are in the English language and encompasses narrative reviews, systemic reviews, meta-analyses, and guidelines. The search term includes all hospital and community pharmacy-related services. Besides, there are national and international guidelines for conducting general research in hospital practice. The pharmacy research committee was formed and comprised numerous expert members, including clinical pharmacists, pharmacists who specialise in drug information, and clinical research specialists. A member drafted the policy{\textquoteright}s guidelines, which were then reviewed and corrected by another member. The research specialist made the third revision. The topic emphasises the Pharmacy Research policy of crosssectional studies design. Results: Pharmacy Research{\textquoteright}s policy on cross-sectional studies design in pharmacy practice covered a variety of topics. This includes an examination of the advantages and disadvantages of cross-sectional studies design, as well as the procedures for conducting cross-sectional research in pharmaceutical care services. Conclusion: A novel initiative in pharmacy practice is the development of a pharmacy research strategy that governs the design of cross-sectional studies. The cross-sectional studies used to develop pharmacy policies increased the number and quality of pharmacy research at public and private healthcare organisations. Thus, the cross-sectional design in pharmacy research policy is a basic foundation to implement in Saudi Arabia.

}, keywords = {Cross-sectional, Pharmacy, Policy, Research, Saudi Arabia.}, doi = {10.5530/ijpcs.2022.11.7}, author = {Yousef Ahmed Alomi and Amal Hassan Al-Najjar and Ghudair Tashan Alanazi and Maha Hussein Almadany and Abeer Hussin Almasoudi} } @article {322, title = {Research Policy on Pharmacy Investigational Medication}, journal = {International Journal of Pharmacology and Clinical Sciences}, volume = {11}, year = {2022}, month = {April 2022}, pages = {09-14}, type = {Review Article}, chapter = {09}, abstract = {

Objectives: This study aims to demonstrate the Research Policy of Pharmacy Investigational Medication as a new initiative in Saudi Arabia. Methods: This article is a narrative review of pharmacy research. Litterateur researched specific research policies and procedures in pharmacy practice using a variety of databases, including PubMed, Medline, and Google Scholar. The time period covered for the search is from the 1960s to October 2021. The terms used are in the English language and encompasses narrative reviews, systemic reviews, meta-analyses, and guidelines. The search term includes all hospital and community pharmacy-related services. Besides, there are national and international guidelines for conducting general research in hospital settings. The pharmacy research committee was formed and comprised numerous expert members, including clinical pharmacists, pharmacists specializing in drug information, and clinical research specialists. A member drafted the policy{\textquoteright}s guidelines, which were then reviewed and corrected by another member. The research specialist made the third revision. The subject emphasizes Pharmacy Research{\textquoteright}s policy on Investigational Medication. Results: The Pharmacy Research policy for Investigational Medication consisted of a number of components, including the administration of pharmacies, the procurement of investigational drugs, and the storage of investigational drugs. Additionally, the investigative drug prescription, the preparation of investigative drugs, the dispensing of investigative drugs, the administration of investigative drugs, and the monitoring of investigative drugs. There were a number of essential policy items, including the safety of investigational medications, the cost of investigational drugs, and the sponsors of investigational drug research. Conclusion: The Pharmacy Research policy for Investigational Medication is a new initiative as part of pharmacy practice research and development. Investigational Medication Pharmacy Research policy helps healthcare organizations improve patient safety and prevent drug-related morbidity and mortality. It is a component of Saudi Arabia{\textquoteright}s pharmacy strategic plan for Vision 2030 and pharmacy reimbursement initiatives.

}, keywords = {Drug, Investigational, Medication, Pharmacy, Policy, Research, Saudi Arabia}, doi = {10.5530/ijpcs.2022.11.3}, author = {Yousef Ahmed Alomi and Amal Hassan Al-Najjar and Hamidah Qasim Ali Abushomi and Maha Hussein Almadany and Abeer Hussin Almasoudi} } @article {332, title = {Research Policy on Research Pharmacist Competency}, journal = {International Journal of Pharmacology and Clinical Sciences}, volume = {11}, year = {2022}, month = {June 2022}, pages = {61-64}, type = {Review Article}, chapter = {61}, abstract = {

Objectives: This study explores the Research policy of Research Pharmacist Competency as a new initiative in Saudi Arabia. Methods: This article is a narrative review of pharmacy research. Litterateur researched specific research policies and procedures in pharmacist competency in research practice using a variety of databases, including PubMed, Medline, and Google Scholar. The period covered for the search is from the 1960s to October 2021. The English language uses the terms and encompasses narrative reviews, systemic reviews, meta-analyses, and guidelines. The search term includes all hospital and community pharmacy-related services. Besides, there are national and international guidelines for conducting general research in hospital practice. The pharmacy research committee was formed and comprised numerous expert members, including clinical pharmacists, pharmacists specializing in drug information, and clinical research specialists. A member drafted the policy{\textquoteright}s guidelines, which were then reviewed and corrected by another member. The research specialist made the third revision. The topic emphasizes the Pharmacy Research policy of pharmacist competencies in Research. Results: The Pharmacist Competency on Pharmacy Research included several items, such as five modules of clinical pharmacist competencies. That consists of Patient care, research skills, communications, Professionalism, and continuing professional development. In addition, each model included a description of the module of various activities, pre-training and post-training exams, type of assessment, and assessment scores. Conclusion: The pharmacy research policy of Research pharmacist competency is a new initiative and a component of the pharmacy strategic plan. The pharmacy policy{\textquoteright}s research pharmacist competency aims to enhance pharmacists{\textquoteright} research abilities and encourage pharmacists to conduct various types of research in multiple settings within the public and healthcare sectors. Therefore, the Research pharmacist competency policy is critical for the pharmacy career in Saudi Arabia.

}, keywords = {Competency, Pharmacy, Policy, Research, Saudi Arabia.}, doi = {10.5530/ijpcs.2022.11.12}, author = {Yousef Ahmed Alomi and Amal Hassan Al-Najjar and Maha Hussein Almadany and Abeer Hussin Almasoudi} } @article {328, title = {Research Quality Management Policy}, journal = {International Journal of Pharmacology and Clinical Sciences}, volume = {11}, year = {2022}, month = {June 2022}, pages = {56-60}, type = {Review Article}, chapter = {56}, abstract = {

Objectives: This study illustrates the Research policy of quality management in pharmacy research practice as a new initiative project in Saudi Arabia. Methods: It is a narrative review of pharmacy research{\textquoteright}s quality management policy and procedures. Litterateur researched specific quality management research policies and procedures in pharmacy practice using various databases, including PubMed, Medline, and Google Scholar. The time covered for the search is from the 1960s to October 2021. The keyword used is in the English language and encompasses systemic reviews, meta-analyses, narrative reviews, and guidelines or regulations. The search term includes all hospital and community pharmacy-related services. Besides, the national and international guidelines for conducting general research in hospital and pharmacy practice. The committee of quality management policy of pharmacy research formulated and consisted of numerous expert members, including clinical pharmacists, drug information pharmacists, and clinical research specialists. A member drafted the policy and procedures, which were then reviewed and corrected by another member. The research specialist made the third revision. The topic emphasizes the quality management of Pharmacy Research policy as the narrative review model. Results: Pharmacy research policy quality management is a new topic in pharmaceutical care services. It covered various topics, the steps involved in conducting quality management, and indicator policies and procedures. Besides, quality management pharmacy research can be implemented into various sections. That included patient care, research skills, communication, Professionalism, cautious development. Each part had a key performance indicator and related optimal level. Conclusion: The quality management policy for pharmacy research is a new initiative within pharmacy research. The quality management pharmacy policy assists the pharmacy research performance and keeps up-to-date development with key performance indicators. Therefore, all quality management models in pharmacy research policy are highly suggested for the pharmacy research practice in Saudi Arabia

}, keywords = {Key performance indicator, Pharmacy, Policy, Quality management, Research, Saudi Arabia.}, doi = {10.5530/ijpcs.2022.11.11}, author = {Yousef Ahmed Alomi and Amal Hassan Al-Najjar and Maha Hussein Almadany and Abeer Hussin Almasoudi} }